$FENCF FENNEC PHARMACEUTICALS INC. Insider Trading
Get free email notifications about insider trading in FENNEC PHARMACEUTICALS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FENNEC PHARMACEUTICALS INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in FENNEC PHARMACEUTICALS INC. for free.
CIK Number: 0001211583
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: FENCF
Company Address: PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK 27709
Phone number: (919) 636-4530
Former name: FENNEC PHARMACEUTICALS, INC., date of change: 2014-09-03
Former name: ADHEREX TECHNOLOGIES INC, date of change: 2002-12-23
Market Capitalization: $30.60M
Prev close: $2.20
Average Daily Volume: 1,498
Days Low: $2.23
Year Low: $1.51
Year High: $3.06
FENNEC PHARMACEUTICALS INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 03 2021 | FENCF | FENNEC PHARMACEUTI ... | Goel Shubh | Chief Commercial Of ... | Option Exercise | A | 7.53 | 100,000 | 753,000 | 100,000 | |
Jun 03 2021 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Option Exercise | A | 7.53 | 100,000 | 753,000 | 100,000 | |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Payment of Exercise | F | 5.71 | 12,874 | 73,511 | 153,273 | 166.1 K to 153.3 K (-7.75 %) |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Payment of Exercise | F | 5.68 | 38,900 | 220,952 | 166,147 | 205 K to 166.1 K (-18.97 %) |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Payment of Exercise | F | 5.77 | 38,828 | 224,038 | 205,047 | 243.9 K to 205 K (-15.92 %) |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Payment of Exercise | F | 6.17 | 97,136 | 599,329 | 243,875 | 341 K to 243.9 K (-28.48 %) |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Buy | M | 1.85 | 323,961 | 599,328 | 341,011 | 17.1 K to 341 K (+1,900.06 %) |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Payment of Exercise | F | 5.71 | 12,093 | 69,051 | 196,578 | 208.7 K to 196.6 K (-5.80 %) |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Payment of Exercise | F | 5.68 | 38,013 | 215,914 | 208,671 | 246.7 K to 208.7 K (-15.41 %) |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Payment of Exercise | F | 5.77 | 37,931 | 218,862 | 246,684 | 284.6 K to 246.7 K (-13.33 %) |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Payment of Exercise | F | 6.17 | 97,136 | 599,329 | 284,615 | 381.8 K to 284.6 K (-25.44 %) |
Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Buy | M | 1.85 | 323,961 | 599,328 | 381,751 | 57.8 K to 381.8 K (+560.58 %) |
Aug 14 2020 | FENCF | FENNEC PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 6.17 | 20,000 | 123,400 | 20,000 | |
Aug 14 2020 | FENCF | FENNEC PHARMACEUTI ... | Islam Khalid | Director | Option Exercise | A | 6.17 | 25,000 | 154,250 | 25,000 | |
Aug 14 2020 | FENCF | FENNEC PHARMACEUTI ... | Haigh Adrian | Director | Option Exercise | A | 6.17 | 20,000 | 123,400 | 20,000 |